GSA Capital Partners’s Kite Pharma, Inc. KITE Stock Holding History

GSA Capital Partners’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,900	Closed	-$672K	–	2071
2015 Q4	$672K	Sell	10,900 -5,120	-32%	-$360K	0.03%	968
2015 Q3	$892K	Sell	16,020 -13,180	-45%	-$829K	0.04%	733
2015 Q2	$1.78M	Sell	29,200 -15,985	-35%	-$912K	0.07%	459
2015 Q1	$2.61M	Buy	+45,185	New	+$3.03M	0.1%	212

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GSA Capital Partners's KITE Position: Q1 2016 in Review

GSA Capital Partners sold out of Kite Pharma, Inc. (KITE) in Q1 2016, closing a stake of 10,900 shares — an estimated $672K sold.

GSA Capital Partners first reported a position in KITE in Q1 2015 and held it in 4 quarters. The position peaked at $2.61M in Q1 2015. 171 funds tracked by Wall St. Rank hold KITE as of Q1 2016.

GSA Capital Partners reported no remaining Kite Pharma, Inc. position as of Q1 2016 after selling out during the quarter.
GSA Capital Partners sold 10,900 Kite Pharma, Inc. shares in Q1 2016, an estimated $672K.
GSA Capital Partners first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 4 quarters.
GSA Capital Partners's Kite Pharma, Inc. position peaked at $2.61M in Q1 2015.
171 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2016.

Based on GSA Capital Partners's 13F filing for Q1 2016, filed 11 May 2016.